Partners Wealth Management LLC acquired a new stake in Counterpoint Quantitative Equity ETF (NYSE:CPAI – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 43,364 shares of the company’s stock, valued at approximately $2,241,000.
Several other institutional investors have also added to or reduced their stakes in the company. Counterpoint Mutual Funds LLC lifted its stake in Counterpoint Quantitative Equity ETF by 5.3% during the first quarter. Counterpoint Mutual Funds LLC now owns 1,549,616 shares of the company’s stock worth $64,758,000 after purchasing an additional 78,500 shares during the last quarter. Nilsine Partners LLC lifted its position in shares of Counterpoint Quantitative Equity ETF by 3.6% during the 2nd quarter. Nilsine Partners LLC now owns 229,706 shares of the company’s stock worth $11,936,000 after buying an additional 8,084 shares during the last quarter. NewEdge Advisors LLC boosted its stake in Counterpoint Quantitative Equity ETF by 230.6% in the second quarter. NewEdge Advisors LLC now owns 111,269 shares of the company’s stock valued at $5,782,000 after buying an additional 77,610 shares in the last quarter. Cetera Investment Advisers boosted its stake in Counterpoint Quantitative Equity ETF by 65.1% in the first quarter. Cetera Investment Advisers now owns 107,891 shares of the company’s stock valued at $4,509,000 after buying an additional 42,559 shares in the last quarter. Finally, Concurrent Investment Advisors LLC boosted its stake in Counterpoint Quantitative Equity ETF by 8.2% in the second quarter. Concurrent Investment Advisors LLC now owns 100,854 shares of the company’s stock valued at $5,240,000 after buying an additional 7,641 shares in the last quarter.
Counterpoint Quantitative Equity ETF Stock Up 0.2%
Counterpoint Quantitative Equity ETF stock opened at $53.70 on Friday. The stock has a market cap of $536.46 million, a PE ratio of -64,388.49 and a beta of 1.18. Counterpoint Quantitative Equity ETF has a 12-month low of $37.29 and a 12-month high of $53.96. The business’s 50-day moving average price is $52.42 and its two-hundred day moving average price is $48.33.
Counterpoint Quantitative Equity ETF Profile
The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.
See Also
- Five stocks we like better than Counterpoint Quantitative Equity ETF
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Want to see what other hedge funds are holding CPAI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Counterpoint Quantitative Equity ETF (NYSE:CPAI – Free Report).
Receive News & Ratings for Counterpoint Quantitative Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Counterpoint Quantitative Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
